CMD BioBanks

Wellstone Center, U of Iowa, Muscle Tissue and Cell Culture Repository
Director: Steven Moore, MD, PhD

The Repository currently contains skeletal muscle biopsies from approximately 3000 neuromuscular disease patients and fibroblast cultures from approximately 10 muscular dystrophy patients. De-identified information about individual biopsies or cultures in the Repository can be found in a searchable database by clicking on the Database link on website above. Research scientists may request tissue from specific biopsies or cell cultures from specific patients by completing the appropriate forms. In order to accrue new biopsies or cell cultures in the Repository, patient consent forms must be completed.

Eurobiobank: CMD Cell Lines

Eurobiobank is a cooperative project linking scientific resources for rare disease, CMD included, between 12 institutional biobanks. Eurobiobank resources are available to international scientists. After following the above link, type in “congenital” in the disease filter (not congenital muscular dystrophy). To access CMD cell resources, email the contact person for that particular biobank.

CMD BioBank
Contact: Tara Schmidlen, MS, CGC ,

By creating a well characterized, central source of samples from individuals with CMDs, Cure CMD and Coriell are working together to facilitate CMD research and invest in the future of CMD therapies. The CMD BioBank will be housed in the National Institute of General Medical Sciences Human Genetic Cell Repository at the Coriell Institute. Samples in the NIGMS repository have been utilized in over 5,000 scientific publications by researchers in more than 50 countries.

Cure CMD will support the CMD BioBank by identifying and facilitating sample transfers from existing collections at other institutions. To provide scientists with a de-identified data set, CMD BioBank samples will be linked to existing profiles in the CMD International Registry through a code number. The CMDIR staff will provide: maximal motor function achieved, breathing status, concomitant medication use and CMD subtype verification. Having detailed information regarding clinical severity assists scientists using the CMD samples in understanding therapy response.

  • Congenital Muscular Dystrophy

    A group of diseases causing muscle weakness at birth. Several defined genetic mutations cause muscles to break down faster than they can repair or grow. A child with CMD may have various neurological or physical impairments. Some children never gain the ability to walk, while others lose the ability as they grow older. Learn more...

  • Register Now!